In other words, the GLP-1 era just got a little simpler
Suitable for hospitals, weight management clinics, pharmacies, and international pharmaceutical distributors
But one researcher, John Cawley, a professor of economics and public policy at Cornell University, and his colleagues found that while obesity basically doubles a persons annual health care costs, the savings associated with public insurance plans covering GLP-1s for just obesity treatment are dependent on the patients body mass index, or BMI
The antioxidant and collagen-support benefits justify the formulation switch during periods of accelerated fat oxidation
New England Journal of Medicine, 381(9), 841-851